Therapeutic Areas and Products
Our world-leading immunoglobulin (Ig) franchise includes an intravenous and a subcutaneous option and is the cornerstone of the neurology therapeutic area. Our efforts in this area focus on bringing trusted products and technologies to serve patients with a rare and serious neurologic disease, Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Efficacy and safety of Privigen® in patients with chronic inflammatory demyelinating polyneuropathy: results of a prospective, single-arm, open-label phase III study (PRIMA)
Léger, J-M et al
J Periph Nerv Syst 2013
Restabilization treatment after IVIg withdrawal in chronic inflammatory demyelinating polyneuropathy. Results from the pre-randomization phase of the PATH study
Mielke, O et al
J Periph Nerv Syst 2019